Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa is a research paper published in British Journal of Clinical Pharmacology (2024). On theSindex it has a DataRank of 0.394. It has been cited 8 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0646
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
Wellcome Trust
Grant: 212265/Z/18/Z
Wellcome Centre for Infectious Diseases Research in Africa
Grant: 203135/Z/16/Z
Fogarty International Center
Grant: D43 TW010559
National Institute of Allergy and Infectious Diseases
Grant: AI077505
National Institute of Allergy and Infectious Diseases
Grant: AI110527
National Institute of Allergy and Infectious Diseases
Grant: TR000445
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068634
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068636
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI106701
National Research Foundation
Grant: UID120647
NIAID NIH HHS
Grant: R01 AI077505
NCATS NIH HHS
Grant: UL1 TR000445
NIAID NIH HHS
Grant: P30 AI110527
NHLBI NIH HHS
Grant: UG3 HL156388
Wellcome Trust
ViiV Healthcare
FWCI
2.44
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals